Loteprednol Etabonate Suspension/ Drops
Product Images NDC 72485-665

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 72485-665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of Loteprednol Etabonate showing its steroid-like molecular framework with detailed bonds and functional groups, consistent with the active ingredient in the Loteprednol Etabonate 5 mg/mL ophthalmic suspension by Armas Pharmaceuticals Inc.*

FDA Label Image

Q0 mL Carton Label (Loteprednol Suspension 0.5 10 mL Carton)

Packaging label for Loteprednol Etabonate Ophthalmic Suspension 0.5%, 10 mL, distributed by Armas Pharmaceuticals, Inc. The label includes directions such as shaking vigorously before use, storage instructions, and preservatives details. It is a sterile ophthalmic suspension for ophthalmic use only, with warnings to keep out of reach of children and not to use if the safety seal is broken. Manufactured in Switzerland by Ophtapharm AG.*

FDA Label Image

10 mL Container Label (Loteprednol Suspension 0.5 10 mL Container)

Label for Loteprednol Etabonate Ophthalmic Suspension 0.5% (5 mg/mL), a 10 mL prescription eye drop. The label instructs to shake vigorously before use, provides storage conditions (store between 15°–25°C, do not freeze), and lists Armas Pharmaceuticals Inc. as the distributor with manufacture in Switzerland. NDC 72485-665 is visible.*

FDA Label Image

15 mL Carton Label (Loteprednol Suspension 0.5 15 mL Carton)

The image shows the carton packaging label for Loteprednol Etabonate Ophthalmic Suspension 0.5%, 15 mL, with NDC 72485-665-15. It lists active ingredient loteprednol etabonate 5 mg/mL and inactive ingredients. The label includes usage instructions such as shaking vigorously before use, storage conditions, and warnings. The product is distributed by Armas Pharmaceuticals, Inc., Freehold, NJ, and manufactured in Switzerland by Ophtapharm AG for Sentiss.*

FDA Label Image

15 mL Container Label (Loteprednol Suspension 0.5 15 mL Container)

Label for Loteprednol Etabonate Ophthalmic Suspension 0.5%, 15 mL bottle. Active ingredient is Loteprednol Etabonate 5 mg/mL. Includes instructions to shake vigorously before use, storage conditions, and distributor information (Armas Pharmaceuticals Inc., Freehold, NJ). Made in Switzerland.*

FDA Label Image

5 mL Carton Label (Loteprednol Suspension 0.5 5 mL Carton)

Label for Loteprednol Etabonate Ophthalmic Suspension, 0.5% (5 mg/mL) in a 5 mL bottle. The label states it is a sterile ophthalmic suspension for prescription use only, distributed by Armas Pharmaceuticals, Inc. It includes active and inactive ingredients, dosage form, storage instructions, and warnings. Manufactured by Ophtapharm AG, Switzerland. The label features barcodes and regulatory information.*

FDA Label Image

5 mL Container Label (Loteprednol Suspension 0.5 5 mL Container)

Label for Loteprednol Etabonate Ophthalmic Suspension 0.5%, 5 mL bottle, an ophthalmic suspension containing 5 mg/mL active ingredient. The label includes instructions to shake vigorously before use, storage conditions, manufacturer details (Armas Pharmaceuticals, Inc.), and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.